These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1060 related articles for article (PubMed ID: 21233507)

  • 1. Clinical significance of microbial infection and adaptation in cystic fibrosis.
    Hauser AR; Jain M; Bar-Meir M; McColley SA
    Clin Microbiol Rev; 2011 Jan; 24(1):29-70. PubMed ID: 21233507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of anaerobic flora in development of bronchopulmonary infection in children with mucoviscidosis].
    Semykin SIu; Postnikov SS; Osipov GA
    Antibiot Khimioter; 2009; 54(3-4):26-8. PubMed ID: 19711846
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease.
    Döring G; Parameswaran IG; Murphy TF
    FEMS Microbiol Rev; 2011 Jan; 35(1):124-46. PubMed ID: 20584083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis: A hereditary disease challenges microbiologists to a duel.
    Heesemann J
    Int J Med Microbiol; 2010 Dec; 300(8):513. PubMed ID: 20940107
    [No Abstract]   [Full Text] [Related]  

  • 5. Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung.
    Quinn RA; Lim YW; Maughan H; Conrad D; Rohwer F; Whiteson KL
    mBio; 2014 Mar; 5(2):e00956-13. PubMed ID: 24643867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial host interactions in cystic fibrosis.
    Callaghan M; McClean S
    Curr Opin Microbiol; 2012 Feb; 15(1):71-7. PubMed ID: 22137884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental evolution can unravel the complex causes of natural selection in clinical infections.
    Brockhurst MA
    Microbiology (Reading); 2015 Jun; 161(6):1175-9. PubMed ID: 25957311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Entanglement: Neutrophil Extracellular Traps (NETs) in Cystic Fibrosis.
    Martínez-Alemán SR; Campos-García L; Palma-Nicolas JP; Hernández-Bello R; González GM; Sánchez-González A
    Front Cell Infect Microbiol; 2017; 7():104. PubMed ID: 28428948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.
    Hurley MN; Smith S; Forrester DL; Smyth AR
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD008037. PubMed ID: 32671834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis.
    Rudkjøbing VB; Thomsen TR; Alhede M; Kragh KN; Nielsen PH; Johansen UR; Givskov M; Høiby N; Bjarnsholt T
    J Clin Microbiol; 2011 Dec; 49(12):4352-5. PubMed ID: 22012018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.
    Hurley MN; Forrester DL; Smyth AR
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD008037. PubMed ID: 23737089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Microbiome in Cystic Fibrosis.
    Huang YJ; LiPuma JJ
    Clin Chest Med; 2016 Mar; 37(1):59-67. PubMed ID: 26857768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine models of acute and chronic lung infection with cystic fibrosis pathogens.
    Bragonzi A
    Int J Med Microbiol; 2010 Dec; 300(8):584-93. PubMed ID: 20951086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy.
    Oliver A
    Int J Med Microbiol; 2010 Dec; 300(8):563-72. PubMed ID: 20837399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates.
    Hogardt M; Ulrich J; Riehn-Kopp H; Tümmler B
    J Clin Microbiol; 2009 Nov; 47(11):3435-8. PubMed ID: 19741077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.
    Hurley MN; Forrester DL; Smyth AR
    Cochrane Database Syst Rev; 2010 Oct; (10):CD008037. PubMed ID: 20927769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of Local Epidemiology in Prevalence and Resistance of Cystic Fibrosis-related Pathogens.
    Hufnagel M; König S; Theilacker C
    Pediatr Infect Dis J; 2016 Feb; 35(2):229. PubMed ID: 26756270
    [No Abstract]   [Full Text] [Related]  

  • 18. Cystic fibrosis: a polymicrobial infectious disease.
    Sibley CD; Rabin H; Surette MG
    Future Microbiol; 2006 Jun; 1(1):53-61. PubMed ID: 17661685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis.
    Cramer N; Wiehlmann L; Tümmler B
    Int J Med Microbiol; 2010 Dec; 300(8):526-33. PubMed ID: 20951087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic and Functional Characterization of Longitudinal Pseudomonas aeruginosa Isolates from Young Patients with Cystic Fibrosis.
    Chandler CE; Hofstaedter CE; Hazen TH; Rasko DA; Ernst RK
    Microbiol Spectr; 2023 Aug; 11(4):e0155623. PubMed ID: 37358436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.